Organon Spins Off from Merck, Focuses on Women's Health
Kevin Ali, CEO of Organon, discusses the company's path forward in women's health after spinning off from Merck.
Cheddar's News Wrap
The latest in news, business, politics, entertainment trends, and more all wrapped up.
Israel Business Weekly